Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX: MCRO)
Egypt
· Delayed Price · Currency is EGP
1.790
+0.070 (4.07%)
At close: Oct 15, 2024
MCRO Revenue
Macro Group Pharmaceuticals (Macro Capital) S.A.E had revenue of 95.72M EGP in the quarter ending June 30, 2024, a decrease of -47.42%. This brings the company's revenue in the last twelve months to 344.02M, down -54.84% year-over-year. In the year 2023, Macro Group Pharmaceuticals (Macro Capital) S.A.E had annual revenue of 526.01M, down -27.91%.
Revenue (ttm)
344.02M
Revenue Growth
-54.84%
P/S Ratio
2.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 526.01M | -203.61M | -27.91% |
Dec 31, 2022 | 729.61M | 135.35M | 22.78% |
Dec 31, 2021 | 594.26M | 163.76M | 38.04% |
Dec 31, 2020 | 430.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition